Diagnostic significance of paradoxical left ventricular hypertrophy in detecting cardiac amyloidosis. 2023

Shingo Ota, and Yasuhiro Izumiya, and Ryoko Kitada, and Takahiro Nishi, and Akira Taruya, and Teruaki Wada, and Masahiro Takahata, and Yuichi Ozaki, and Manabu Kashiwagi, and Yasutsugu Shiono, and Akio Kuroi, and Kazushi Takemoto, and Takashi Tanimoto, and Hironori Kitabata, and Daiju Fukuda, and Atsushi Tanaka
Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Cardiac amyloidosis (CA) progresses rapidly with a poor prognosis. Therefore, methods for early diagnosis that are easily accessible in any hospital, are required. We hypothesized that based on the pathology of CA, morphological left ventricular hypertrophy (LVH) without electrical augmentation, namely paradoxical LVH, could be used to diagnose CA. This study aimed to investigate whether paradoxical LVH has diagnostic significance in identifying CA in patients with LVH. Patients who presented with left ventricular (LV) wall thickness ≥ 12 mm on cardiac magnetic resonance (CMR) were enrolled from a multicentre CMR registry. Paradoxical LVH was defined as a LV wall thickness ≥ 12 mm on CMR, SV1 + RV5 < 3.5 mV, and a lack of secondary ST-T abnormalities. The diagnostic significance of paradoxical LVH in identifying CA was assessed. Of the 110 patients enrolled, 30 (27 %) were diagnosed with CA and 80 (73 %) with a non-CA aetiology. The CA group demonstrated paradoxical LVH more frequently than the non-CA group (80 % vs. 16 %, P < 0.001). It was an independent predictor for detecting CA in patients with LVH (odds ratio: 33.44, 95 % confidence interval: 8.325-134.3, P < 0.001). The sensitivity, specificity, positive predict value, negative predict value and accuracy of paradoxical LVH for CA detection were 80 %, 84 %, 65 %, 92 % and 83 %, respectively. Paradoxical LVH can be used for identifying CA in patients with LVH. Our findings could contribute to the early diagnosis of CA, even in non-specialized hospitals.

UI MeSH Term Description Entries

Related Publications

Shingo Ota, and Yasuhiro Izumiya, and Ryoko Kitada, and Takahiro Nishi, and Akira Taruya, and Teruaki Wada, and Masahiro Takahata, and Yuichi Ozaki, and Manabu Kashiwagi, and Yasutsugu Shiono, and Akio Kuroi, and Kazushi Takemoto, and Takashi Tanimoto, and Hironori Kitabata, and Daiju Fukuda, and Atsushi Tanaka
March 1990, Postgraduate medicine,
Shingo Ota, and Yasuhiro Izumiya, and Ryoko Kitada, and Takahiro Nishi, and Akira Taruya, and Teruaki Wada, and Masahiro Takahata, and Yuichi Ozaki, and Manabu Kashiwagi, and Yasutsugu Shiono, and Akio Kuroi, and Kazushi Takemoto, and Takashi Tanimoto, and Hironori Kitabata, and Daiju Fukuda, and Atsushi Tanaka
May 2023, Cureus,
Shingo Ota, and Yasuhiro Izumiya, and Ryoko Kitada, and Takahiro Nishi, and Akira Taruya, and Teruaki Wada, and Masahiro Takahata, and Yuichi Ozaki, and Manabu Kashiwagi, and Yasutsugu Shiono, and Akio Kuroi, and Kazushi Takemoto, and Takashi Tanimoto, and Hironori Kitabata, and Daiju Fukuda, and Atsushi Tanaka
January 1996, Ryoikibetsu shokogun shirizu,
Shingo Ota, and Yasuhiro Izumiya, and Ryoko Kitada, and Takahiro Nishi, and Akira Taruya, and Teruaki Wada, and Masahiro Takahata, and Yuichi Ozaki, and Manabu Kashiwagi, and Yasutsugu Shiono, and Akio Kuroi, and Kazushi Takemoto, and Takashi Tanimoto, and Hironori Kitabata, and Daiju Fukuda, and Atsushi Tanaka
June 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis,
Shingo Ota, and Yasuhiro Izumiya, and Ryoko Kitada, and Takahiro Nishi, and Akira Taruya, and Teruaki Wada, and Masahiro Takahata, and Yuichi Ozaki, and Manabu Kashiwagi, and Yasutsugu Shiono, and Akio Kuroi, and Kazushi Takemoto, and Takashi Tanimoto, and Hironori Kitabata, and Daiju Fukuda, and Atsushi Tanaka
October 2021, European heart journal. Cardiovascular Imaging,
Shingo Ota, and Yasuhiro Izumiya, and Ryoko Kitada, and Takahiro Nishi, and Akira Taruya, and Teruaki Wada, and Masahiro Takahata, and Yuichi Ozaki, and Manabu Kashiwagi, and Yasutsugu Shiono, and Akio Kuroi, and Kazushi Takemoto, and Takashi Tanimoto, and Hironori Kitabata, and Daiju Fukuda, and Atsushi Tanaka
September 1998, Vnitrni lekarstvi,
Shingo Ota, and Yasuhiro Izumiya, and Ryoko Kitada, and Takahiro Nishi, and Akira Taruya, and Teruaki Wada, and Masahiro Takahata, and Yuichi Ozaki, and Manabu Kashiwagi, and Yasutsugu Shiono, and Akio Kuroi, and Kazushi Takemoto, and Takashi Tanimoto, and Hironori Kitabata, and Daiju Fukuda, and Atsushi Tanaka
January 2023, Cardiology journal,
Shingo Ota, and Yasuhiro Izumiya, and Ryoko Kitada, and Takahiro Nishi, and Akira Taruya, and Teruaki Wada, and Masahiro Takahata, and Yuichi Ozaki, and Manabu Kashiwagi, and Yasutsugu Shiono, and Akio Kuroi, and Kazushi Takemoto, and Takashi Tanimoto, and Hironori Kitabata, and Daiju Fukuda, and Atsushi Tanaka
March 1992, Clinical nuclear medicine,
Shingo Ota, and Yasuhiro Izumiya, and Ryoko Kitada, and Takahiro Nishi, and Akira Taruya, and Teruaki Wada, and Masahiro Takahata, and Yuichi Ozaki, and Manabu Kashiwagi, and Yasutsugu Shiono, and Akio Kuroi, and Kazushi Takemoto, and Takashi Tanimoto, and Hironori Kitabata, and Daiju Fukuda, and Atsushi Tanaka
January 2010, Archives of cardiovascular diseases,
Shingo Ota, and Yasuhiro Izumiya, and Ryoko Kitada, and Takahiro Nishi, and Akira Taruya, and Teruaki Wada, and Masahiro Takahata, and Yuichi Ozaki, and Manabu Kashiwagi, and Yasutsugu Shiono, and Akio Kuroi, and Kazushi Takemoto, and Takashi Tanimoto, and Hironori Kitabata, and Daiju Fukuda, and Atsushi Tanaka
January 1997, Advances in experimental medicine and biology,
Copied contents to your clipboard!